BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22502733)

  • 1. Prognostic significance of lymphovascular invasion in radical prostatectomy specimens.
    Ng J; Mahmud A; Bass B; Brundage M
    BJU Int; 2012 Nov; 110(10):1507-14. PubMed ID: 22502733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of lymphovascular invasion is an independent prognostic factor for biochemical recurrence after radical prostatectomy.
    Fajkovic H; Mathieu R; Lucca I; Hiess M; Hübner N; Al Hussein Al Awamlh B; Lee R; Briganti A; Karakiewicz P; Lotan Y; Roupret M; Rink M; Kluth L; Loidl W; Seitz C; Klatte T; Kramer G; Susani M; Shariat SF
    Urol Oncol; 2016 May; 34(5):233.e1-6. PubMed ID: 26973136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of lymphovascular invasion in radical prostatectomy specimens.
    Yee DS; Shariat SF; Lowrance WT; Maschino AC; Savage CJ; Cronin AM; Scardino PT; Eastham JA
    BJU Int; 2011 Aug; 108(4):502-7. PubMed ID: 21050364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphovascular invasion in prostate cancer: prognostic significance in patients treated with radiotherapy after radical prostatectomy.
    Brooks JP; Albert PS; O'Connell J; McLeod DG; Poggi MM
    Cancer; 2006 Apr; 106(7):1521-6. PubMed ID: 16518811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Routinely reported 'equivocal' lymphovascular invasion in prostatectomy specimens is associated with adverse outcomes.
    Galiabovitch E; Hovens CM; Peters JS; Costello AJ; Battye S; Norden S; Ryan A; Corcoran NM
    BJU Int; 2017 Apr; 119(4):567-572. PubMed ID: 27431748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of lymphovascular invasion in radical prostatectomy specimens.
    May M; Kaufmann O; Hammermann F; Loy V; Siegsmund M
    BJU Int; 2007 Mar; 99(3):539-44. PubMed ID: 17155973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphovascular invasion is an independent predictor of prostate-specific antigen failure after radical prostatectomy in patients with pT3aN0 prostate cancer.
    Yamamoto S; Kawakami S; Yonese J; Fujii Y; Ohkubo Y; Suyama T; Komai Y; Kijima T; Ishikawa Y; Fukui I
    Int J Urol; 2008 Oct; 15(10):895-9. PubMed ID: 18721204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
    J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of lymphovascular invasion in radical prostatectomy: a systematic review and meta-analysis.
    Huang Y; Huang H; Pan XW; Xu DF; Cui XG; Chen J; Hong Y; Gao Y; Yin L; Ye JQ; Li L
    Asian J Androl; 2016; 18(5):780-5. PubMed ID: 26459779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphovascular invasion in radical prostatectomy specimens: prediction of adverse pathologic features and biochemical progression.
    Loeb S; Roehl KA; Yu X; Antenor JA; Han M; Gashti SN; Yang XJ; Catalona WJ
    Urology; 2006 Jul; 68(1):99-103. PubMed ID: 16806410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphovascular invasion is a pathological feature related to aggressive cancer behavior and predicts early recurrence in prostate cancer.
    Luo HL; Chiang PH; Chen YT; Cheng YT
    Kaohsiung J Med Sci; 2012 Jun; 28(6):327-30. PubMed ID: 22632888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perineural invasion is a prognostic factor for biochemical failure after radical prostatectomy.
    Jeon HG; Bae J; Yi JS; Hwang IS; Lee SE; Lee E
    Int J Urol; 2009 Aug; 16(8):682-6. PubMed ID: 19602004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of lymphovascular invasion in clinically localized prostate cancer after radical prostatectomy.
    Baydar DE; Baseskioglu B; Ozen H; Geyik PO
    ScientificWorldJournal; 2008 Mar; 8():303-12. PubMed ID: 18379707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphovascular invasion is a pathological feature of biologically aggressive disease in patients treated with radical prostatectomy.
    Shariat SF; Khoddami SM; Saboorian H; Koeneman KS; Sagalowsky AI; Cadeddu JA; McConnell JD; Holmes MN; Roehrborn CG
    J Urol; 2004 Mar; 171(3):1122-7. PubMed ID: 14767284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphovascular invasion is significantly associated with biochemical relapse after radical prostatectomy even in patients with pT2N0 negative resection margin.
    Mitsuzuka K; Narita S; Koie T; Kaiho Y; Tsuchiya N; Yoneyama T; Kakoi N; Kawamura S; Tochigi T; Ohyama C; Habuchi T; Arai Y
    Prostate Cancer Prostatic Dis; 2015 Mar; 18(1):25-30. PubMed ID: 25330857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of lymphovascular invasion on lymph node metastasis for patients undergoing radical prostatectomy with negative resection margin.
    Kang YJ; Kim HS; Jang WS; Kwon JK; Yoon CY; Lee JY; Cho KS; Ham WS; Choi YD
    BMC Cancer; 2017 May; 17(1):321. PubMed ID: 28482884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of pathological factors on oncological outcomes after robot-assisted radical prostatectomy for localized prostate cancer: Results of a prospective study.
    Kozal S; Peyronnet B; Cattarino S; Seisen T; Comperat E; Vaessen C; Mozer P; Renard-Penna R; Cussenot O; Rouprêt M; Drouin SJ
    Urol Oncol; 2015 Jul; 33(7):330.e1-7. PubMed ID: 25998747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited value of perineural invasion in radical prostatectomy specimens as a predictor of biochemical recurrence in Japanese men with clinically localized prostate cancer.
    Miyake H; Sakai I; Harada K; Eto H; Hara I
    Hinyokika Kiyo; 2005 Apr; 51(4):241-6. PubMed ID: 15912782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of lymphovascular invasion in patients with prostate cancer following radical prostatectomy and its association with their clinicopathological features: An updated PRISMA-compliant systematic review and meta-analysis.
    Jiang W; Zhang L; Wu B; Zha Z; Zhao H; Jun Y; Jiang Y
    Medicine (Baltimore); 2018 Dec; 97(49):e13537. PubMed ID: 30544460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphovascular invasion as a predictor of disease progression in prostate cancer.
    Herman CM; Wilcox GE; Kattan MW; Scardino PT; Wheeler TM
    Am J Surg Pathol; 2000 Jun; 24(6):859-63. PubMed ID: 10843289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.